Divisional Patents Remain Divisive In Europe

Legal Conference Hears Of Continuing ‘Pernicious Effects’ On Generic Entry And Access

Divisional patents remain a major barrier to market entry for generics in Europe, heard attendees to Medicines for Europe’s legal affairs conference in Dublin earlier this month.

Arrows splitting off, blue, divisional patent concept
Divisional patents are still catching generics in their web • Source: Shutterstock

More from Legal & IP

More from Generics Bulletin